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Abstract
Background: Gastroesophageal reflux disease (GERD) is a common cause of discomfort and morbidity worldwide. However,
information on determinants of GERD from large-scale studies in low- to medium-income countries is limited. We
investigated the factors associated with different measures of GERD symptoms, including frequency, patient-perceived
severity, and onset time.
Methods: We performed a cross-sectional analysis of the baseline data from a population-based cohort study of ,50,000
individuals in in Golestan Province, Iran. GERD symptoms in this study included regurgitation and/or heartburn.
Results: Approximately 20% of participants reported at least weekly symptoms. Daily symptoms were less commonly
reported by men, those of Turkmen ethnicity, and nass chewers. On the other hand, age, body mass index, alcohol drinking,
cigarette smoking, opium use, lower socioeconomic status, and lower physical activity were associated with daily
symptoms. Most of these factors showed similar associations with severe symptoms. Women with higher BMI and waist to
hip ratio were more likely to report frequent and severe GERD symptoms. Hookah smoking (OR 1.34, 95% CI 1.02–1.75) and
opium use (OR 1.70, 95% CI 1.55–1.87) were associated with severe symptoms, whereas nass chewing had an inverse
association (OR 0.87, 95% CI 0.76–0.99). After exclusion of cigarette smokers, hookah smoking was still positively associated
and nass chewing was inversely associated with GERD symptoms (all frequencies combined).
Conclusion: GERD is common in this population. The associations of hookah and opium use and inverse association of nass
use with GERD symptoms are reported for the first time. Further studies are required to investigate the nature of these
associations. Other determinants of GERD were mostly comparable to those reported elsewhere.
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Introduction
Gastroesophageal reflux disease (GERD) has increased in
Europe and the United States over the past decades [1–3]. GERD
symptoms are among the most common gastrointestinal symptoms
in those regions [4], with prevalence rates of 10–25% reported
from population-based studies [2,5–8]. Several population-based
studies from Iran, in West Asia, have reported prevalence rates
similar to those in Western countries [9–11]. The incidence of
GERD is increasing in Iran [12], and currently it is the most
common outpatient gastrointestinal disease encountered there
[13].
Determinants of GERD in the general population have been
examined in a number of studies [14–24], but some potential
determinants have shown conflicting results and are yet to be
established. Also, data from low- to medium income countries are
limited, as only a few of the population-based studies on
determinants of GERD have been conducted in those countries
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[25–30]. We aimed to investigate determinants of prevalent
GERD with cross-sectional analysis of the baseline data from the
Golestan Cohort Study, a prospective cohort of over 50,000
individuals in Golestan Province, in northeastern Iran. We
analyzed the data on frequency, patient-perceived severity, and
the time of the first episode of GERD symptoms.
Methods
Study Population
The Golestan Cohort Study was primarily designed to
investigate risk factors for upper gastrointestinal cancers. The
design of this cohort has been described elsewhere [31]. Briefly,
the Golestan Cohort Study is a prospective population-based
cohort of 40–75 years old individuals in eastern parts of Golestan
Province, Iran. Urban inhabitants in the specified age range were
selected randomly from Gonbad City, the main urban area in
eastern Golestan, by systematic clustering based on the household
number. In rural areas, all residents of 326 villages in the study
catchment area in the specified age range were invited to
participate. A total of 50,045 adults without history of upper
gastrointestinal cancers were enrolled in the study between
January 2004 and June 2008.
Ethics Statement
Written consent was obtained from all participants. The
conduct of the Golestan Cohort Study, including the consent
procedure, was approved by the Institutional Review Boards of the
Digestive Disease Research Center of Tehran University of
Medical Sciences, the US National Cancer Institute, and the
International Agency for Research on Cancer.
Exposure Measurements
At baseline, trained nurses and physicians conducted face-to-
face interviews using structured questionnaires to collect data on
GERD, potential determinants of GERD, and confounding
factors. Weight, height, and waist and hip circumferences were
measured by trained research staff. Body mass index (BMI) was
calculated by dividing weight (kg) by the squared value of height
(m).
Individuals who had ever used alcohol, cigarettes, hookah (also
known as water-pipe, shisha, nargileh, and qalyan), nass (a mixture
of tobacco, lime, and ash), or opium at least once a week for a
period of 6 months or more were considered as users of the
respective substance. In hookah smoking, tobacco is placed at the
top of the hookah inside a bowl, which is separated with a
perforated metal foil from burning coal placed on top [32].
Hookah smoke passes through a water basin and cools down, and
then it is inhaled using a hose attached to the upper part of the
water basin (Figure 1). Some people may believe that hookah
smoking is harmless, assuming that its harmful compounds are
filtered in the water [32]. However, there are several biomarker
studies in humans that have shown appreciable amounts of
tobacco related-compounds following hookah smoking [33–35],
refuting the harmlessness of hookah. Although cigarette and
hookah are both tobacco smoking produzcts, we considered them
as separate entities because patterns of use of these products might
be different, and there have been few published studies on the
association between hookah smoking and GERD. We calculated
cumulative amount of cigarette use (as pack-years) using data on
duration and quantity of use. In accord with our earlier
publications [36], we calculated a composite score for wealth by
applying multiple correspondence analysis to appliance ownership
data (including personal car, motorbike, black and white TV, color
TV, refrigerator, freezer, vacuum cleaner, and washing machine).
We only considered occupational physical activity because
recreational physical activity is uncommon in the study popula-
tion.
Outcome Measurements
We asked the study participants about having regurgitation or
heartburn over the past year and prior to the past year. Those with
any either the symptoms in either time period were considered as
having GERD symptoms. The frequency of GERD symptoms was
recorded as never, occasional (including those associated with
certain foods or drinks only), 1–3 times/month, once a week, 2–6
times/week, and daily. We combined the frequencies as never, ,
weekly (combination of occasional and 1–3 times/month), weekly
(combination of once a week and 2–6 times/week), and daily for
our analyses. We also asked about the severity of symptoms, which
were categorized as: ‘‘mild’’, the study participant did not feel the
symptoms unless they actively paid attention; ‘‘moderate’’, the
study participant felt the symptom anyway, but it did not interfere
with daily work; and ‘‘severe’’, symptoms interfering with daily
work or causing night-time awakenings. The frequency and
severity of GERD symptoms were asked separately for the past
year and for prior to one year before the interview. As the reported
frequencies and severities for these two periods were comparable
(Table S1) and we had another variable on the starting time of the
symptoms, we combined the data and considered the most
frequent frequency and the most severe severity of GERD
symptoms in either of the two periods as the usual frequency
and severity of symptoms, respectively. The first episode of GERD
was recorded as within the last year, and 1–5, 6–10, or .10 years
ago.
Statistical Analysis
The number of individuals with missing values in all GERD
variables (,0.1% of the cohort participants) and in individual
Figure 1. Diagram of a hookah. Source: Wikipedia (http://en.
wikipedia.org/wiki/File:Hookah-lookthrough.svg), after modification.
doi:10.1371/journal.pone.0089256.g001
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GERD variables (,0.7% for each of the variables) was small, so
the first group was excluded from the current analyses, and the
second group was excluded from the analyses of the respective
variable. Numbers and percentages were calculated and presented
for categorical variables, as well as means and standard deviations
for continuous variables. Odds ratios (ORs) and 95% confidence
intervals (95% CIs) for the association of sociodemographic and
lifestyle factors and anthropometric indices with frequency and
severity of GERD symptoms were calculated using multinomial
logistic regression models. In the analyses of frequency, ,weekly,
weekly, and daily symptoms, and in the analyses of severity, mild,
moderate, and severe symptoms, as separate categories were
compared with never having GERD symptoms. P values for trend
were obtained from the same multinomial logistic regression
models by assigning consecutive numbers to categories within each
categorical variable.
Multivariate models were adjusted for several potential
confounding factors as indicated in the table footnotes. As
participants in our study could have shifted from using cigarettes
to hookah or nass following the development of GERD, we also
investigated the associations between hookah and nass use and
GERD among never-cigarette smokers. All statistical analyses
were performed using Stata statistical software version 11 (Stata
Corporation, College Station, Texas, USA). All reported P values
are two-sided, and P,0.05 was considered to be statistically
significant.
Results
Data on reflux were available for 50,001 individuals. Approx-
imately 12% of participants reported daily and 11% reported
severe GERD symptoms; 16% of participants reported GERD
symptoms with the first episode happening .10 years before the
interview (Table 1).
Daily GERD symptoms had inverse associations with being a
male (OR 0.36, 95% CI 0.33–0.39) or of Turkmen ethnicity (OR
0.66, 95% CI 0.61–0.70), formal education (Ptrend 0.01), wealth
score (Ptrend ,0.001), regular non-intense physical activity (OR
0.90, 95% CI 0.83–0.98), and nass chewing (OR 0.86, 95% CI
0.75–0.98) (Table 2). On the other hand, daily symptoms were
positively associated with older age (7% increase in risk per 10-
year increase in age), higher BMI (Ptrend ,0.001), alcohol drinking
(OR 1.36, 95% CI 1.13–1.64), cigarette smoking (OR 1.43, 95%
CI 1.23–1.67 for smoking $20 pack-years), and opium use (OR
1.82, 95% CI 1.67–1.99). The association between age and daily
symptoms was linear (data not shown).
Being a male, having formal education or higher wealth scores,
and chewing nass were inversely associated with reporting severe
symptoms (Table 2). On the other hand, severe symptoms were
positively associated with BMI, alcohol drinking, or cigarette,
hookah, or opium use. In never cigarette smokers (Table 3),
hookah smoking was positively associated (OR 1.26, 95% CI
1.01–1.56) and nass chewing was inversely associated (OR 0.85,
95% CI 0.76–0.94) with GERD symptoms (any frequency or
severity combined).
The associations with,weekly and weekly symptoms (Table S2)
or mild to moderate symptoms (Table S3) in most cases were
similar to those of daily or severe symptoms, respectively.
However, those with education levels of above high school were
more likely to report ,weekly or mild to moderate symptoms than
those with no formal education.
The associations of cigarette smoking and opium use and
inverse association of nass use were stronger with longer duration
of the time period between the onset of GERD symptoms and
baseline interview (Table S4). As expected, age was also associated
with this duration.
In women, both higher BMI and higher waist to hip ratio were
associated with daily and severe symptoms (Table 4). The
association between waist to hip ratio and reflux symptoms
persisted after adjustments for BMI, suggesting an independent
role of central obesity in GERD in women. Waist to hip ratio
showed a trend of association with daily GERD symptoms in men
(P for trend 0.04), but this association attenuated after adjustment
for BMI. None of the categories of BMI or waist to hip ratio had
statistically significant associations with GERD symptoms in men.
The patterns of association between waist circumference and
GERD symptoms in men and women were comparable with those
of waist to hip ratio and GERD (data not shown).
Discussion
In this study, approximately 20% of participants had weekly or
more frequent GERD symptoms. Several sociodemographic and
lifestyle factors were associated with GERD symptoms. Many of
these associations have been reported in other populations. We
found an association between hookah or opium use and GERD
symptoms and an inverse association between nass use and the
symptoms for the first time. To the best of our knowledge, this is
one of the largest studies on determinants of GERD symptoms
worldwide and by far the largest study in low- and medium-
income countries [37].
Alcohol, Tobacco, and Opium Use
Associations of alcohol drinking and cigarette smoking with
GERD symptoms and esophagitis have previously been reported
(generally with OR ,2), although these associations have not been
shown in all studies [28,38,39]. We found modest but statistically
significant associations between alcohol or cigarette use and
Table 1. GERD symptoms in 50,001 individuals with data on
GERD in the Golestan Cohort Study.
GERD symptoms Number (%)
Symptom frequency
Never 19,560 (39.12)
,Weekly 20,471 (40.94)
Weekly 4029 (8.06)
Daily 5915 (11.83)
Missing 26 (0.05)
Symptom severity
Mild 4449 (8.90)
Moderate 20,315 (40.63)
Severe 5663 (11.33)
Missing 16 (0.03)
Symptom start
,1 year ago 5326 (10.65)
1–5 years ago 12,534 (25.07)
6–10 years ago 4444 (8.89)
.10 years ago 7895 (15.79)
Missing 304 (0.61)
GERD, gastroesophageal reflux disease.
doi:10.1371/journal.pone.0089256.t001
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Table 2. Association of several demographic and lifestyle factors with daily and severe GERD symptoms.
Variables All No symptoms Daily symptoms Severe symptoms
N (%) N (%) N (%) OR (95% CI) N (%) OR (95% CI)
Total 50,001 (100) 19,560 (100) 5915 (100) – 5663 (100) –
Age * 52.1 (9.0) 52.1 (9.0) 52.7 (9.2) 1.07 (1.04–1.11) 52.2 (8.9) 1.01 (0.98–1.05)
Sex
Women 28,785 (57.57) 9947 (50.85) 4241 (71.70) Referent 3981 (70.30) Referent
Men 21,216 (42.43) 9613 (49.15) 1674 (28.30) 0.36 (0.33–0.39) 1682 (29.70) 0.36 (0.33–0.39)
Ethnicity
Non-Turkmen 12,786 (25.57) 4913 (25.12) 2001 (33.83) Referent 1477 (26.08) Referent
Turkmen 37,215 (74.43) 14,647 (74.88) 3914 (66.17) 0.66 (0.61–0.70) 4186 (73.92) 0.98 (0.91–1.06)
Residence
Rural 39,366 (78.73) 15,962 (81.61) 4802 (81.18) Referent 4518 (79.78) Referent
Urban 10,634 (21.27) 3598 (18.39) 1113 (18.82) 1.01 (0.93–1.11) 1145 (20.22) 1.13 (1.04–1.23)
Education
No school 35,089 (70.18) 13,319 (68.09) 4672 (78.99) Referent 4444 (78.47) Referent
1–8th grade 10,698 (21.40) 4479 (22.90) 985 (16.65) 0.92 (0.84–1.00) 919 (16.23) 0.84 (0.77–0.93)
High School 3150 (6.30) 1342 (6.86) 197 (3.33) 0.78 (0.66–0.93) 220 (3.88) 0.73 (0.62–0.87)
Higher 1064 (2.13) 420 (2.15) 61 (1.03) 0.92 (0.69–1.23) 80 (1.41) 0.99 (0.76–1.29)
P for trend 0.01 0.001
Wealth score
Quintile 1-lowest 13,455 (26.91) 5089 (26.02) 1948 (32.93) Referent 1888 (33.34) Referent
Quintile 2 8469 (16.94) 3394 (17.35) 976 (16.50) 0.86 (0.79–0.94) 936 (16.53) 0.80 (0.73–0.87)
Quintile 3 9790 (19.58) 3845 (19.66) 1180 (19.95) 0.90 (0.83–0.98) 1111 (19.62) 0.80 (0.73–0.87)
Quintile 4 8345 (16.69) 3344 (17.10) 933 (15.77) 0.82 (0.75–0.90) 801 (14.14) 0.66 (0.60–0.73)
Quintile 5 9942 (19.88) 3888 (19.88) 878 (14.84) 0.68 (0.61–0.75) 927 (16.37) 0.65 (0.59–0.72)
P for trend ,0.001 ,0.001
Body mass index
,18.5 kg/m2 2410 (4.82) 989 (5.06) 324 (5.48) 0.94 (0.81–1.07) 298 (5.26) 0.96 (0.83–1.11)
18.5–24.9 17,914 (35.83) 7452 (38.11) 2083 (35.23) Referent 1953 (34.50) Referent
25–29.9 16,958 (33.92) 6576 (33.63) 1945 (32.89) 1.11 (1.04–1.20) 1840 (32.50) 1.10 (1.02–1.18)
$30 12,710 (25.42) 4539 (23.21) 1561 (26.40) 1.15 (1.06–1.25) 1570 (27.73) 1.21 (1.11–1.31)
P for trend ,0.001 ,0.001
Physical activity
Irregular non-intense 30,619 (61.44) 11,579 (59.36) 4235 (71.86) Referent 3750 (66.37) Referent
Regular non-intense 13,524 (27.14) 5411 (27.74) 1086 (18.43) 0.90 (0.83–0.98) 1416 (25.06) 1.28 (1.18–1.38)
Regular or irregular intense 5691 (11.42) 2518 12.91) 572 (9.71) 0.94 (0.84–1.05) 484 (8.57) 0.97 (0.87–1.09)
P for trend 0.04 0.04
Alcohol drinking
Never 48,274 (96.55) 18917 (96.71) 5740 (97.04) Referent 5460 (96.42) Referent
Ever 1727 (3.45) 643 (3.29) 175 (2.96) 1.36 (1.13–1.64) 203 (3.58) 1.53 (1.28–1.83)
Cigarette smoking
Never 41,409 (82.84) 16,186 (82.77) 5066 (85.65) Referent 4804 (84.83) Referent
0.1–5 pack-years 2764 (5.53) 1118 (5.72) 268 (4.53) 1.20 (1.04–1.40) 266 (4.70) 1.24 (1.07–1.45)
5.1–10 1261 (2.52) 490 (2.51) 122 (2.06) 1.37 (1.10–1.70) 126 (2.22) 1.42 (1.15–1.76)
10.1–20 1799 (3.60) 692 (3.54) 154 (2.60) 1.21 (1.00–1.46) 177 (3.13) 1.40 (1.16–1.68)
$20 2753 (5.51) 1069 (5.47) 305 (5.16) 1.43 (1.23–1.67) 290 (5.12) 1.42 (1.22–1.66)
P for trend ,0.001 ,0.001
Hookah smoking
Never 49,445 (98.93) 19,379 (99.12) 5812 (98.31) Referent 5578 (98.55) Referent
Ever 533 (1.07) 173 (0.88) 100 (1.69) 1.19 (0.92–1.54) 82 (1.45) 1.34 (1.02–1.75)
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GERD symptoms, with a significant exposure-response trend for
the latter. Cigarette smoking usually starts in young adulthood, so
temporal relationship between this habit and GERD is likely.
Ever hookah smoking was also associated with GERD. The
association between hookah smoking and GERD (any symptoms)
persisted even after exclusion of cigarette smokers. Among never
cigarette smokers, hookah smoking had statistically significant or
borderline significant associations with mild and moderate GERD
symptoms, but the association with severe symptoms was non-
significant. The number of hookah smokers with severe symptoms
was modest, which may be a reason for the above pattern. The
magnitude of association was slightly stronger with mild to
moderate symptoms. This may be because many hookah smokers
in our study smoked hookah recreationally and with relatively low
frequencies, so the symptoms associated with hookah smoking
might be more likely to be mild to moderate. In fact,
approximately half of the hookah smokers in this study had
smoked less than 11 unit-years, which was equivalent to smoking
hookah only once a day for 11 years (data not shown). Due to the
modest number of hookah smokers in our study, we were not able
to investigate the association by categories of use. The association
between hookah use and GERD symptoms may be explainable by
the comparability of the exposures in cigarette and hookah
smoking [40]. Cigarette smoking increases frequency of gastro-
esophageal reflux episodes by reducing the lower esophageal
sphincter pressure [41] and reduces salivary secretion of bicar-
bonates [42]. However, some other mechanisms might also be
involved in the association between hookah smoking and GERD
symptooms. For example, mean puff volume in hookah smoking is
generally over 500 mL [33,43,44], which is several times bigger
than usual puff volumes in cigarette smoking (40–70 mL) [43].
Therefore, hookah smoking can induce strong negative intra-
thoracic pressure and increase thoraco-abdominal pressure
gradient, which may increase gastroesophageal reflux [45].
The reasons for the inverse association of nass use and positive
association of opium use with GERD symptoms in our study are
unclear. Nass contains tobacco specific N-nitroso compounds and
volatile N-nitrosamines, but the levels of these compounds in nass
seem to be lower than in chewing tobacco products in Western
countries [46,47]. Besides tobacco-related compounds, nass
contains other compounds that are added during processing and
have unknown effects on GERD symptoms. These ingredients
increase the pH of nass to above 11 [46], whereas the pH of many
other chewing tobacco products is between five to seven [46,48].
The alkaline pH of nass may outweigh the potential harmful
effects of tobacco with regard to GERD symptoms and may play a
role in the inverse association between nass and the symptoms.
Furthermore, using nass may be associated with increased saliva
secretion and frequent swallowing, and similar to chewing gum
[49,50], it may reduce esophageal acid exposure. Morphine may
reduce acid reflux in GERD patients [51], but the effects of
morphine on GERD symptoms are unclear. Opium also contains
several compounds other than morphine, including other opiate
alkaloids (such as papaverine), non-alkaloid compounds from
opium poppy (such as meconic acid), and other compounds added
or generated during processing or smoking, including heterocyclic
and polycyclic aromatic hydrocarbons and primary aromatic
amines [52–55], which may have various, but yet unknown, effects
on GERD symptoms. Opium is usually ingested or smoked [56].
The associations of hookah, nass, and opium use with GERD
may all be true, but all of them were modest and may in part be
related to the effects of unknown confounding factors or residual
confounding. Furthermore, opium use might be secondary to the
development of GERD symptoms, as some patients in this
population may use opium for alleviation of their symptoms
[56]. On the other hand, as hookah and cigarette smoke have
several common compounds, a casual association between hookah
smoking and GERD symptoms is plausible, assuming that
cigarette smoking is causally associated with GERD. To the best
of our knowledge, this is the first report on the association of
hookah, nass, and opium use with GERD symptoms, and these
associations merit further scrutiny. The investigations on hookah
smoking may be of particular interest, as the prevalence of hookah
smoking has been increasing among young adults in many
populations, including in some European and North American
countries [32].
Sociodemographic Factors
Several, but not all [28,38,57], studies have reported a positive
association between age and GERD, either as a linear association
[26,58] or with a peak and a slight decrease afterwards [59–61].
The histological damage in the esophageal epithelium, including
esophagitis, may be more common in the elderly than in younger
individuals [62–64], but older people may report severe symptoms
Table 2. Cont.
Variables All No symptoms Daily symptoms Severe symptoms
N (%) N (%) N (%) OR (95% CI) N (%) OR (95% CI)
Nass chewing
Never 46,224 (92.45) 17,989 (91.97) 5529 (93.47) Referent 5300 (93.59) Referent
Ever 3773 (7.55) 1570 (8.03) 386 (6.53) 0.86 (0.75–0.98) 363 (6.41) 0.87 (0.76–0.99)
Opium use
Never 41,507 (83.02) 16,540 (84.56) 4738 (80.13) Referent 4573 (80.78) Referent
Ever 8488 (16.98) 3020 (15.44) 1175 (19.87) 1.82 (1.67–1.99) 1088 (19.22) 1.70 (1.55–1.87)
CI, confidence interval; GERD, gastroesophageal reflux disease; OR, odds ratio.
Numbers may not add up to the total numbers due to missing data. The ORs (95% CIs) were calculated using multinomial logistic regression models. In the analyses of
frequency, ,weekly, weekly, and daily symptoms, and in the analyses of severity, mild, moderate, and severe symptoms, as separate categories were compared with
never having GERD symptoms. Results for ,weekly and weekly symptoms are shown in Table S2. Results for mild and moderate symptoms are shown in Table S3. The
ORs (95% CIs) are from multivariate models in which all the variables shown in this table were included.
* For age, the values are mean (standard deviation) years. Age was included in the models as a continuous variable, but the ORs (95% CIs) are shown here on a 10-year
scale.
doi:10.1371/journal.pone.0089256.t002
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less frequently [64]. In our study, age had a linear association with
daily symptoms but was not associated with severe symptoms.
Although the association between age and GERD appears to be
causal, cohort effect may also play a role in the observed patterns
of association, as the majority of the evidence comes from cross-
sectional rather than longitudinal studies.
The current evidence on the association between gender and
GERD symptoms is mixed, but the majority of studies have not
shown any association [65]. However, in most studies with
endoscopy, non-erosive GERD have been more common in
women [66], whereas erosive esophagitis have been more common
in men [65–67]. The reported prevalence of symptoms and
histological damage related to GERD varies across ethnic/racial
groups [68,69]. We found a difference in prevalence of daily
symptoms (but not in the severity of symptoms) between Turkmens
and non-Turkmens. It is not clear what environmental and/or
genetic factors contribute to these differences. The average
perception of GERD symptoms may also vary in different
socioeconomic and demographic groups, for example in ethnic/
racial groups or in men and women [70]. At least part of the
observed differences in the association of sociodemographic groups
with GERD may be related to these differences in perception.
An association between poor socioeconomic status and GERD
has been reported in other populations [18,60,71]. Our results also
showed such an association even after adjustments for several
other determinants of GERD. Reverse causality appears unlikely
to explain the inverse association between education level and
GERD, particularly for lower education levels, because education
is usually started and completed at an early age, usually before the
onset of GERD [60]. In our study, education levels of 1st–8th grade
and high school were the most commonly attained levels among
those with formal education, and both showed inverse associations
with daily and severe GERD symptoms. As socioeconomic status
is not a biologic factor, the factors that are associated with
socioeconomic status which may influence GERD symptoms need
further investigations.
Anthropometric Indices
The majority of previous studies have shown an association
between higher BMI and GERD symptoms [72,73]. Central
adiposity seems to be a more important factor in this association
than overall obesity [74]. The association between obesity and
GERD seems to be causal, as exposure–response associations have
been reported in multiple studies [72,73], obesity has been
associated with histological indicators of esophageal epithelium
damage [72,74], and weight loss has been associated with
decreased GERD symptoms [15,17].
Increased intra-abdominal pressure or thoraco-abdominal
pressure gradients may be among the main possible explanations
for the association of GERD with BMI and, in particular, central
obesity [45,75]. However, there seems to be other mechanisms
contributing to this association, including reduced lower esopha-
geal sphincter pressure in obese individuals [75,76]. In any case,
esophageal acid exposure has been positively associated with BMI
[75] and waist circumference [76,77]. The association between
esophageal acid exposure and waist circumference has been
reported in both groups of people with [76] or without [77]
GERD symptoms.
In our study, high BMI and central obesity were associated with
GERD symptoms in women. In men, central obesity showed
trends for association with daily symptoms, but categories of
neither BMI nor waist to hip ratio had significant associations with
GERD symptoms. A stronger association between obesity and
GERD symptoms or esophagitis in women [15,70,78], and an
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association between estrogen hormone therapy and GERD
[15,79] have previously been reported. However, several other
studies have not shown a difference in the association between
obesity and GERD by gender [68,80]. The reasons for this
variation in results are unclear. Some speculative explanations
include: other risk factors for GERD may be so common in a
population (or a subpopulation, such as men) that they may reduce
the apparent effect of obesity. Also, we cannot exclude presence of
unknown confounding factors or residual confounding. Further-
more, anthropometric indices may change after development of
GERD. In this case, losing or gaining weight can reduce or
increase, respectively, the association between obesity and GERD
in cross-sectional studies.
Table 4. Association between anthropometric indices and daily and severe GERD symptoms by sex.
All
participants
No
symptoms Daily symptoms Severe symptoms
Variables N (%) N (%) N (%) OR 1 (95% CI) OR 2 (95% CI) N (%) OR 1 (95% CI) OR 2 (95% CI)
Women 28,785 (100) 9947 (100) 4241 (100) 3981 (100)
Body mass index
,18.5 kg/m2 1153 (4.01) 411 (4.13) 324 (5.48) 0.87 (0.72–1.05) – 298 (5.26) 0.91 (0.75–1.11) –
18.5–24.9 8311 (28.88) 3049 (30.66) 2083 (35.23) Referent – 1953 (34.50) Referent –
25.0–29.9 9691 (33.67) 3348 (33.66) 1945 (32.89) 1.12 (1.02–1.22) – 1840 (32.50) 1.12 (1.02–1.23) –
$30 9627 (33.45) 3138 (31.55) 1561 (26.40) 1.21 (1.10–1.33) – 1570 (27.73) 1.30 (1.18–1.43) –
P for trend ,0.001 – ,0.001
Waist to hip ratio
WHO Criteria
Normal 3091 (10.74) 1249 (12.56) 414 (9.77) Referent Referent 390 (9.81) Referent Referent
At risk ($0.85) 25,680 (89.26) 8692 (87.44) 3824 (90.23) 1.34 (1.19–1.51) 1.25 (1.09–1.43) 3587 (90.19) 1.32 (1.17–1.49) 1.21 (1.05–1.38)
Quintiles
,0.882 5551 (19.29) 2186 (21.99) 727 (17.15) Referent Referent 694 (17.45) Referent Referent
0.882–0.934 5772 (20.06) 1981 (19.93) 782 (18.45) 1.21 (1.07–1.36) 1.20 (1.06–1.36) 7376 (18.53) 1.18 (1.05–1.34) 1.15 (1.02–1.31)
0.935–0.978 5595 (19.45) 1919 (19.30) 824 (19.44) 1.33 (1.18–1.49) 1.31 (1.16–1.50) 813 (20.44) 1.34 (1.19–1.51) 1.29 (1.13–1.47)
0.979–1.027 5850 (20.33) 1909 (19.20) 904 (21.33) 1.43 (1.27–1.61) 1.42 (1.24–1.62) 1466 (20.64) 1.35 (1.20–1.53) 1.28 (1.12–1.47)
$1.028 6003 (20.86) 1946 (19.58) 1001 (23.62) 1.52 (1.35–1.71) 1.50 (1.31–1.72) 1570 (22.93) 1.46 (1.29–1.65) 1.36 (1.18–1.57)
P for trend ,0.001 ,0.001 ,0.001 ,0.001
Men 21216 (100) 9613 (100) 1674 (100) 1682 (100)
Body mass index
,18.5 kg/m2 1257 (5.93) 578 (6.01) 324 (5.48) 1.03 (0.84–1.27) – 298 (5.26) 1.02 (0.82–1.26) –
18.5–24.9 9603 (45.28) 4403 (45.82) 2083 (53.23) Referent – 1953 (34.50) Referent –
25.0–29.9 7267 (34.26) 3228 (33.59) 1945 (32.89) 1.11 (0.98–1.25) – 1840 (32.50) 1.08 (0.96–1.22) –
$30 3083 (14.54) 1401 (14.58) 1561 (26.40) 1.06 (0.90–1.26) – 1570 (27.73) 1.01 (0.85–1.19) –
P for trend 0.17 0.42
Waist to hip ratio
WHO Criteria
Normal 5457 (25.74) 2550 (26.55) 465 (27.79) Referent Referent 483 (28.75) Referent Referent
At risk ($0.90) 15741 (74.26) 7054 (73.45) 1208 (72.21) 1.10 (0.97–1.24) 1.08 (0.93–1.24) 1197 (71.25) 1.05 (0.93–1.18) 1.03 (0.89–1.18)
Quintiles
,0.883 4204 (19.83) 1980 (20.62) 361 (21.58) Referent Referent 375 (22.32) Referent Referent
0.883–0.929 4048 (19.10) 1789 (18.63) 324 (19.37) 1.04 (0.88–1.23) 1.05 (0.88–1.24) 321 (19.11) 1.01 (0.85–1.18) 1.00 (0.85–1.19)
0.930–0.971 4351 (20.53) 1954 (20.35) 324 (19.37) 1.05 (0.89–1.24) 1.05 (0.87–1.26) 339 (20.18) 1.06 (0.90–1.25) 1.05 (0.87–1.25)
0.972–1.018 4217 (19.89) 1868 (19.45) 321 (19.19) 1.14 (0.96–1.34) 1.13 (0.93–1.38) 332 (19.76) 1.13 (0.95–1.33) 1.11 (0.91–1.34)
$1.019 4378 (20.65) 2013 (20.96) 343 (20.50) 1.15 (0.97–1.36) 1.15 (0.93–1.42) 313 (18.63) 1.02 (0.87–1.21) 1.01 (0.81–1.25)
P for trend 0.04 0.09 0.37 0.58
CI, confidence interval; GERD, gastroesophageal reflux disease; OR, odds ratio; WHO, World Health Organization.
Numbers may not add up to the total numbers due to missing data. The ORs (95% CIs) were calculated using multinomial logistic regression models. In the analyses of
frequency, ,weekly, weekly, and daily symptoms, and in the analyses of severity, mild, moderate, and severe symptoms, as separate categories were compared with
never having GERD symptoms. Results for,weekly, weekly, mild, and moderate symptoms are not shown. OR 1s (95% CIs) were adjusted for age, sex, ethnicity, place of
residence, education, wealth score, physical activity, consumption of alcohol, cigarette, hookah, nass, and opium (variables as shown in Table 2). OR 2s (95% CIs) were
additionally adjusted for body mass index.
doi:10.1371/journal.pone.0089256.t004
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Physical Activity
Although vigorous exercise has been associated with GERD
[81], moderate physical activity may have an inverse association
with GERD symptoms in the general population [30,82] or in
obese patients only [83]. A study has also suggested a positive
association between physical activity at work and GERD
symptoms but an inverse association with recreational physical
activity [84]. In our study, the associations between occupational
physical activity and frequency or severity of GERD symptoms
were mixed. These conflicting results may partly be related to
variation in the definition and assessment of physical activity
across studies. Also, a clinical trial has shown that actively training
the diaphragm by breathing exercise may relieve GERD
symptoms [85]. Therefore, different types of exercise and physical
activity may have various effects on GERD depending on their
impact on different parts of the body. Further longitudinal studies
in this regard using standard measurement methods are required.
Strengths and Limitations of the Study
A relatively large sample size, collection of detailed information
on GERD symptoms and other factors, and adjustments for
multiple potential confounding factors are among the strengths of
this study. One limitation was the lack of data on endoscopic and
histological damage associated with GERD. However, as GERD is
a clinical diagnosis in most instances, especially in the primary care
setting, and its symptoms are a common source of discomfort
regardless of the presence or absence of endoscopic and histologic
findings, investigation of determinants of GERD per se may have
clinical implications. Another limitation was that we collected data
only on regurgitation and heartburn and not on less common
symptoms of GERD. However, the common definition of GERD
is based on regurgitation and heartburn, and most studies have
used this definition. Furthermore, using other less specific
symptoms might have introduced substantial measurement error.
For example, GERD can cause cough [38], but cough can also be
related to many other disorders [86].
Cross-sectional studies may not be able to ascertain the
temporal relationship between exposures and outcomes. However,
this may not be a major drawback for some socio-demographic
factors, including age, sex, ethnicity, and education. On the other
hand, we did not analyze the collected dietary data (which covered
dietary intakes over the one year before the interview) because of
the probability of a modification in diet following GERD
symptoms. However, we adjusted the results for several factors
that may be important indicators of original dietary patterns,
including age, ethnicity, place of residence (rural/urban), educa-
tion, and wealth, in order to reduce the potential confounding
effect of diet on the observed associations. The temporal
relationships for other factors are discussed in their respective
sections above. We were not able to consider in our analyses the
use of medications for relieving GERD symptoms. However, as we
considered the most frequent and severe symptoms anytime in life
as the frequency and severity of symptoms in respective
participants, any alleviation of symptoms following the use of
medications is unlikely to have had major effects on the observed
associations.
Conclusions
GERD is common in Golestan Province. Several factors
associated with GERD in other populations were associated with
GERD in our study as well. We also observed associations of
hookah and opium use and an inverse association of nass use with
GERD. These associations, like many other currently known ones,
may not be causal and merit further investigation. Several
modifiable lifestyle factors have consistently been associated with
GERD. The possibility that modifying these factors may alleviate
or prevent GERD symptoms needs to be clarified in controlled
studies.
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